Hippo/Yap Signaling in Cardiac Development and Regeneration

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

1. 1.
   Edgar BA. From cell structure to transcription: Hippo forges a new path. Cell. 2006;124(2):267–73.CrossRefPubMedGoogle Scholar
2. 2.••
   Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL, et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science. 2011;332(6028):458–61. Pioneer work demonstrated Hippo signaling interacting with Wnt signaling suppresses cardiomyocyte proliferation.CrossRefPubMedPubMedCentralGoogle Scholar
3. 3.•
   von Gise A, Lin Z, Schlegelmilch K, Honor LB, Pan GM, Buck JN, et al. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc Natl Acad Sci U S A. 2012;109(7):2394–9. Follow-up study of Heallen et al Science 2011 demonstrated Hippo signaling effect Yap acting through TEAD is sufficient to stimulate neonatal cardiomyocyte proliferation.CrossRefGoogle Scholar
4. 4.•
   Xin M, Kim Y, Sutherland LB, Qi X, McAnally J, Schwartz RJ, et al. Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci Signal. 2011;4(196):ra70. Follow-up study of Heallen et al Science 2011, showed Yap connects to β-catenin through activating IGF signaling in cardiac growth regulation.CrossRefPubMedPubMedCentralGoogle Scholar
5. 5.
   Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y, et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell. 2009;16(5):425–38.CrossRefPubMedPubMedCentralGoogle Scholar
6. 6.
   Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP/TAZ in mechanotransduction. Nature. 2011;474(7350):179–83.CrossRefPubMedGoogle Scholar
7. 7.
   Fernandez BG, Gaspar P, Bras-Pereira C, Jezowska B, Rebelo SR, Janody F. Actin-capping protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila. Development. 2011;138(11):2337–46.CrossRefPubMedGoogle Scholar
8. 8.
   Sansores-Garcia L, Bossuyt W, Wada K, Yonemura S, Tao C, Sasaki H, et al. Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J. 2011;30(12):2325–35.CrossRefPubMedPubMedCentralGoogle Scholar
9. 9.
   Wada K, Itoga K, Okano T, Yonemura S, Sasaki H. Hippo pathway regulation by cell morphology and stress fibers. Development. 2011;138(18):3907–14.CrossRefPubMedGoogle Scholar
10. 10.
    Calvo F, Ege N, Grande-Garcia A, Hooper S, Jenkins RP, Chaudhry SI, et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol. 2013;15(6):637–46.CrossRefPubMedGoogle Scholar
11. 11.
    Kikuchi K, Holdway JE, Werdich AA, Anderson RM, Fang Y, Egnaczyk GF, et al. Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature. 2010;464(7288):601–5.CrossRefPubMedPubMedCentralGoogle Scholar
12. 12.
    Poss KD. Getting to the heart of regeneration in zebrafish. Semin Cell Dev Biol. 2007;18(1):36–45.CrossRefPubMedGoogle Scholar
13. 13.
    Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009;324(5923):98–102.CrossRefPubMedPubMedCentralGoogle Scholar
14. 14.
    Kajstura J, Rota M, Cappetta D, Ogorek B, Arranto C, Bai Y, et al. Cardiomyogenesis in the aging and failing human heart. Circulation. 2012;126(15):1869–81.CrossRefPubMedPubMedCentralGoogle Scholar
15. 15.
    Mollova M, Bersell K, Walsh S, Savla J, Das LT, Park SY, et al. Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci U S A. 2013;110(4):1446–51.CrossRefPubMedPubMedCentralGoogle Scholar
16. 16.
    Senyo SE, Steinhauser ML, Pizzimenti CL, Yang VK, Cai L, Wang M, et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature. 2013;493(7432):433–6.CrossRefPubMedPubMedCentralGoogle Scholar
17. 17.••
    Xin M, Kim Y, Sutherland LB, Murakami M, Qi X, McAnally J, et al. Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci U S A. 2013;110(34):13839–44. First time illustrated activating Yap promotes adult mammalian heart regeneration.CrossRefPubMedPubMedCentralGoogle Scholar
18. 18.••
    Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN, et al. Transient regenerative potential of the neonatal mouse heart. Science. 2011;331(6020):1078–80. First time shown that newborn mice have heart regeneration ability within the first week after birth, which aroused wide interests in the mechanism study.CrossRefPubMedPubMedCentralGoogle Scholar
19. 19.
    Heallen T, Morikawa Y, Leach J, Tao G, Willerson JT, Johnson RL, et al. Hippo signaling impedes adult heart regeneration. Development. 2013;140(23):4683–90.CrossRefPubMedPubMedCentralGoogle Scholar
20. 20.
    Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol. 2011;13(8):877–83.CrossRefPubMedPubMedCentralGoogle Scholar
21. 21.
    Matsui Y, Nakano N, Shao D, Gao S, Luo W, Hong C, et al. Lats2 is a negative regulator of myocyte size in the heart. Circ Res. 2008;103(11):1309–18.CrossRefPubMedPubMedCentralGoogle Scholar
22. 22.
    Odashima M, Usui S, Takagi H, Hong C, Liu J, Yokota M, et al. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction. Circ Res. 2007;100(9):1344–52.CrossRefPubMedGoogle Scholar
23. 23.
    Yamamoto S, Yang G, Zablocki D, Liu J, Hong C, Kim SJ, et al. Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. J Clin Invest. 2003;111(10):1463–74.CrossRefPubMedPubMedCentralGoogle Scholar
24. 24.
    Del Re DP, Yang Y, Nakano N, Cho J, Zhai P, Yamamoto T, et al. Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury. J Biol Chem. 2013;288(6):3977–88.CrossRefPubMedPubMedCentralGoogle Scholar
25. 25.
    Imajo M, Miyatake K, Iimura A, Miyamoto A, Nishida E. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/beta-catenin signalling. The EMBO journal. 2012;31(5):1109–22.CrossRefPubMedPubMedCentralGoogle Scholar
26. 26.
    Tian Y, Liu Y, Wang T, Zhou N, Kong J, Chen L, et al. A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice. Sci Transl Med. 2015;7(279):279ra238.CrossRefGoogle Scholar
27. 27.
    Lin Z, von Gise A, Zhou P, Gu F, Ma Q, Jiang J, et al. Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model. Circ Res. 2014;115(3):354–63.CrossRefPubMedPubMedCentralGoogle Scholar
28. 28.
    Lin Z, Zhou P, von Gise A, Gu F, Ma Q, Chen J, et al. Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. Circ Res. 2015;116(1):35–45.CrossRefPubMedPubMedCentralGoogle Scholar
29. 29.•
    Morikawa Y, Zhang M, Heallen T, Leach J, Tao G, Xiao Y, et al. Actin cytoskeletal remodeling with protrusion formation is essential for heart regeneration in Hippo-deficient mice. Sci Signal. 2015;8(375):ra41. This paper discovered Hippo signaling suppresses cytoskeleton remodeling and cell protrusion, which are required for heart regeneration.CrossRefPubMedPubMedCentralGoogle Scholar
30. 30.
    Hong KU, Bolli R. Cardiac stem cell therapy for cardiac repair. Curr Treat Options Cardiovasc Med. 2014;16(7):324.CrossRefPubMedPubMedCentralGoogle Scholar
31. 31.
    Chong JJ, Chandrakanthan V, Xaymardan M, Asli NS, Li J, Ahmed I, et al. Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell. 2011;9(6):527–40.CrossRefPubMedPubMedCentralGoogle Scholar
32. 32.
    Imajo M, Ebisuya M, Nishida E. Dual role of YAP and TAZ in renewal of the intestinal epithelium. Nat Cell Biol. 2015;17(1):7–19.CrossRefPubMedGoogle Scholar
33. 33.
    Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science. 2005;309(5737):1074–8.CrossRefPubMedGoogle Scholar
34. 34.
    Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, et al. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell. 2009;139(4):757–69.CrossRefPubMedPubMedCentralGoogle Scholar
35. 35.
    Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006;126(4):677–89.CrossRefPubMedGoogle Scholar
36. 36.
    Mosqueira D, Pagliari S, Uto K, Ebara M, Romanazzo S, Escobedo-Lucea C, et al. Hippo pathway effectors control cardiac progenitor cell fate by acting as dynamic sensors of substrate mechanics and nanostructure. ACS Nano. 2014;8(3):2033–47.CrossRefPubMedGoogle Scholar
37. 37.
    Jacot JG, Martin JC, Hunt DL. Mechanobiology of cardiomyocyte development. J Biomech. 2010;43(1):93–8.CrossRefPubMedPubMedCentralGoogle Scholar
38. 38.
    Song K, Nam YJ, Luo X, Qi X, Tan W, Huang GN, et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature. 2012;485(7400):599–604.CrossRefPubMedPubMedCentralGoogle Scholar
39. 39.
    Sadahiro T, Yamanaka S, Ieda M. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications. Circ Res. 2015;116(8):1378–91.CrossRefPubMedGoogle Scholar
40. 40.
    Qin H, Blaschke K, Wei G, Ohi Y, Blouin L, Qi Z, et al. Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming. Hum Mol Genet. 2012;21(9):2054–67.CrossRefPubMedPubMedCentralGoogle Scholar
41. 41.
    Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther. 2009;123(2):255–78.CrossRefPubMedGoogle Scholar
42. 42.
    Del Re DP, Matsuda T, Zhai P, Gao S, Clark GJ, Van Der Weyden L, et al. Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice. J Clin Invest. 2010;120(10):3555–67.CrossRefPubMedPubMedCentralGoogle Scholar